Update
$Intensity Therapeutics(INTS.US$ Intensity Therapeutics Announced A Business Update Reflecting Progress In Its Phase 3 Sarcoma Clinical Program; FDA Provided "Study May Proceed Letter" For Phase 3 Within 30 Day Period Following IND Submission
Benzinga· 3 mins ago![]()
Benzinga· 3 mins ago
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
